Pregnancy- and lactation-associated osteoporosis (PLO) is a rare condition causing fragile bones and fractures during late pregnancy or early postpartum, most commonly affecting the spine. According to Gram Research analysis of international medical guidelines, diagnosis requires clinical examination, blood tests, and imaging to rule out other causes of bone loss. Treatment focuses on adequate calcium and vitamin D intake, with individualized medication options including teriparatide, abaloparatide, or romosozumab for severe cases, alongside effective contraception if medications are used.
Pregnancy and breastfeeding can sometimes cause a rare condition called pregnancy- and lactation-associated osteoporosis (PLO), where bones become fragile and break easily, especially in the spine. According to Gram Research analysis of international medical guidelines, this condition requires careful diagnosis and personalized treatment. A team of six major medical organizations reviewed all available evidence to create clear recommendations for doctors on how to identify, diagnose, and treat PLO. The good news is that with proper calcium and vitamin D intake, and sometimes medication, women with this condition can protect their bones and prevent future fractures.
Key Statistics
A 2026 position statement from six international medical organizations identified pregnancy- and lactation-associated osteoporosis as a rare syndrome characterized by fragility fractures, most commonly multiple vertebral fractures occurring in late pregnancy or the early postpartum period.
According to the 2026 international guidelines, preferred medication treatments for pregnancy- and lactation-associated osteoporosis are teriparatide, abaloparatide, or romosozumab, with denosumab or bisphosphonates as second-choice options, all requiring individualized evaluation and effective contraception.
The 2026 medical consensus recommends that all pregnant and postpartum women ensure adequate calcium intake of 1000-1200 mg daily and vitamin D supplementation of 600-800 IU daily or higher if deficient, as a foundation for treating pregnancy- and lactation-associated osteoporosis.
A 2026 international review noted that bisphosphonates used to treat pregnancy- and lactation-associated osteoporosis can cross the placental barrier and remain detectable in bone for years, prompting preference for alternative medications when possible.
The Quick Take
- What they studied: How to best identify, diagnose, and treat pregnancy- and lactation-associated osteoporosis (PLO), a rare condition where bones become weak during pregnancy or breastfeeding
- Who participated: This was a review of existing research by six international medical organizations, not a study of individual patients. They looked at all published studies about PLO to create treatment guidelines
- Key finding: PLO is rare but serious, causing fragile bones that break easily—especially in the spine. Doctors should use specific tests and imaging to diagnose it, and treatment should be customized for each woman based on whether she’s pregnant or already had her baby
- What it means for you: If you’re pregnant or breastfeeding and experience unusual bone pain or fractures, ask your doctor about PLO. Early diagnosis and treatment with calcium, vitamin D, and sometimes medication can prevent serious fractures. Talk to your doctor before starting any new treatments, especially if you might become pregnant again
The Research Details
Six major international medical organizations—including groups focused on pregnancy medicine, bone health, and women’s health—worked together to review all the scientific evidence about pregnancy- and lactation-associated osteoporosis. They looked at individual research studies, examining how well they were designed, how many people participated, how long patients were followed, and whether treatments were safe. Because PLO is rare, there aren’t many large controlled studies available, so the organizations had to carefully evaluate the quality of existing research to make their recommendations.
The review focused on three main areas: how doctors should diagnose PLO, what tests and imaging they should use, and what treatments work best. The organizations considered both non-medication approaches (like increasing calcium and vitamin D) and medication options. They also looked at special concerns for pregnant and breastfeeding women, since many bone medications can pass to the baby or through breast milk.
This type of review is important because it brings together the best available evidence from around the world and creates practical guidelines that doctors can use. Rather than relying on single studies, which might be small or limited, this approach looks at the whole picture of what we know about PLO.
Because PLO is rare, individual research studies are small and limited. By reviewing all available evidence together, these medical organizations could create reliable guidelines that help doctors recognize and treat the condition consistently. This matters because women with PLO need prompt diagnosis and treatment to prevent serious fractures that could affect their long-term health and ability to care for their babies.
This review was created by six respected international medical organizations with expertise in pregnancy, bone health, and women’s medicine. The organizations carefully evaluated existing studies based on their design quality, size, and safety data. However, because PLO is rare, the evidence base is limited—there aren’t many large, well-controlled studies available. The recommendations are based on the best evidence currently available, but some treatment decisions may need to be individualized. The guidelines are meant to help doctors make decisions, not to replace individual medical judgment.
What the Results Show
Pregnancy- and lactation-associated osteoporosis is a rare but serious condition where bones become fragile during late pregnancy or shortly after delivery. The most common fractures occur in the spine and are often multiple. Women with PLO may experience sudden bone pain or fractures without obvious injury.
Doctors should diagnose PLO using three main approaches: a detailed physical exam and medical history, blood tests to rule out other causes of bone loss, and imaging (like X-rays or bone density scans) to confirm weak bones. The guidelines recommend checking for other conditions that could cause bone loss, such as thyroid problems or vitamin D deficiency, before diagnosing PLO.
Treatment depends on whether the woman is still pregnant or already postpartum. All women should ensure adequate calcium and vitamin D intake through diet or supplements. Pain relief medication may be needed. In some cases, doctors may recommend stopping breastfeeding to help bones recover. For more severe cases, bone-specific medications may be considered, though these require careful individual evaluation.
The organizations identified three preferred medication options: teriparatide and abaloparatide (which stimulate bone formation) and romosozumab (which works on bone cells). Second-choice options include denosumab or bisphosphonates. Importantly, if medications are used, women must use effective contraception because some bone medications can harm future pregnancies.
The review emphasized that bisphosphonates—a common bone medication—can cross the placenta and remain in bones for years. While no harmful effects on future pregnancies have been reported yet, the organizations recommend caution and prefer other medication options when possible. The guidelines stress that treatment decisions should be individualized based on each woman’s specific situation, including how severe her bone loss is, whether she’s still pregnant, and her plans for future pregnancies. Long-term follow-up care is important to monitor bone recovery and prevent future fractures.
This position statement represents the most current international consensus on PLO, bringing together guidance from six major medical organizations. It builds on previous research by providing practical, step-by-step recommendations for diagnosis and treatment. The emphasis on individualized treatment plans and careful medication selection reflects growing awareness that PLO requires specialized care that balances bone health with pregnancy safety.
The main limitation is that PLO is rare, so there are very few large, well-controlled research studies available. Most evidence comes from small studies or case reports rather than large clinical trials. This means some treatment recommendations are based on expert opinion rather than strong scientific proof. Additionally, because the condition is rare, long-term follow-up data on treatment outcomes is limited. The guidelines acknowledge that some treatment decisions will need to be made on a case-by-case basis rather than following a one-size-fits-all approach.
The Bottom Line
Women experiencing bone pain or fractures during pregnancy or early postpartum should ask their doctor about PLO evaluation. Ensure adequate calcium (1000-1200 mg daily) and vitamin D (600-800 IU daily, or more if deficient) through diet or supplements—this is recommended for all pregnant and breastfeeding women. If PLO is diagnosed, work with your doctor to create an individualized treatment plan. If bone medications are prescribed, use effective contraception. Have regular follow-up appointments to monitor bone recovery. Confidence level: High for calcium/vitamin D supplementation; Moderate for medication choices, as evidence is limited due to the rarity of the condition.
Pregnant women and women in the early postpartum period, especially those experiencing unusual bone pain or fractures. Women with risk factors for bone loss (family history of osteoporosis, low body weight, limited sun exposure, dietary restrictions). Healthcare providers caring for pregnant and postpartum women. Women planning future pregnancies who have had PLO. Women should NOT assume they have PLO based on normal pregnancy-related bone changes—diagnosis requires specific testing.
Bone pain or fractures from PLO typically appear in late pregnancy or within the first few months after delivery. With proper treatment, bone recovery can begin within weeks to months, though complete recovery may take 6-12 months or longer. Medication effects on bone density may take 3-6 months to become apparent. Regular monitoring is recommended to track progress.
Frequently Asked Questions
Can pregnancy cause permanent bone loss and osteoporosis?
Pregnancy can cause temporary bone loss, but permanent osteoporosis is rare. Pregnancy- and lactation-associated osteoporosis (PLO) is an uncommon condition causing fragile bones and fractures during late pregnancy or early postpartum. Most women recover bone density after pregnancy with adequate calcium and vitamin D.
What should I do if I have bone pain while pregnant or breastfeeding?
Contact your doctor immediately. Unusual bone pain during pregnancy or postpartum may indicate pregnancy- and lactation-associated osteoporosis. Your doctor can perform tests and imaging to diagnose the condition and recommend treatment, which typically includes calcium and vitamin D supplementation and may include medication.
Is it safe to take bone medication while breastfeeding?
Some bone medications can pass into breast milk or affect future pregnancies. The 2026 international guidelines recommend preferred medications like teriparatide or romosozumab over bisphosphonates. Any bone medication requires individual evaluation by your doctor and effective contraception if you might become pregnant again.
How much calcium and vitamin D do I need during pregnancy and breastfeeding?
The international guidelines recommend 1000-1200 mg of calcium daily and 600-800 IU of vitamin D daily during pregnancy and breastfeeding. If you’re deficient in vitamin D, your doctor may recommend higher doses. These amounts can come from food sources or supplements.
Will my bones recover after pregnancy if I have osteoporosis?
With proper treatment including adequate calcium, vitamin D, and sometimes medication, bone recovery can begin within weeks to months. Complete recovery may take 6-12 months or longer. Regular monitoring helps track progress and prevent future fractures.
Want to Apply This Research?
- Log daily calcium and vitamin D intake (target: 1000-1200 mg calcium, 600-800+ IU vitamin D), bone pain episodes with location and severity (1-10 scale), and any fractures or injuries. Track these weekly to identify patterns and share with your healthcare provider.
- Set daily reminders to take calcium and vitamin D supplements at the same time each day. Use the app to log food sources of calcium (dairy, leafy greens, fortified products) to track dietary intake. If prescribed bone medication, set reminders for doses and track adherence. Log any bone-related symptoms to discuss with your doctor at appointments.
- Create a monthly summary report of calcium/vitamin D intake, symptom frequency, and medication adherence to share with your healthcare provider. Set quarterly check-in reminders to review progress toward bone health goals. If follow-up bone density scans are ordered, log results in the app to track bone recovery over time. Use the app to maintain a list of questions for your doctor about bone health during pregnancy and postpartum.
This article summarizes international medical guidelines on pregnancy- and lactation-associated osteoporosis for educational purposes. It is not a substitute for professional medical advice, diagnosis, or treatment. If you experience bone pain, fractures, or other symptoms during pregnancy or postpartum, consult your healthcare provider immediately. Do not start, stop, or change any medications without discussing with your doctor, especially if you are pregnant, breastfeeding, or planning future pregnancies. Some bone medications can affect pregnancy and require effective contraception. Individual treatment decisions should be made with your healthcare team based on your specific medical situation.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.